dihexa renal toxicity study Effect of Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single‐Dose Phase 1 - Mittur - 2026 - Clinical Pharmacology in Drug Development Dihexa (PNB-0408) | Angiotensin IV
Description
The data isnt there yet
The maximum studied and approved dose is 15 mg
Reik, 2007)
No banlist data has been recorded for this card
[DOI] [PubMed] [Google Scholar] 250.Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, Ting JP
